Skip to content

Clinical evaluation of polymp active zinc to decrease dentinal hipersensibility

Clinical evaluation of polymp active (Zn) to decrease dentinal hipersensibility

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7twgjp6
Enrollment
Unknown
Registered
2023-08-28
Start date
2023-10-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dentin Sensitivity

Interventions

No drugs. A 21-day double-blind, parallel, prospective, equivalence controlled clinical trial will be performed. 60 patients will be recruited as they seek treatment at university clinics. Patients wi

Sponsors

Andres Felipe felipe Millan Cardenas
Lead Sponsor
Centro Universitário de Maranhão - UNICEUMA
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Good oral and general health; be at least 18 years of age; probing depth less than 3 millimeters, dentin sensitivity; have at least 2 teeth and a maximum of 4 teeth with non-carious cervical lesions

Exclusion criteria

Exclusion criteria: Patients with advanced periodontal disease; severe or chronic periodontitis; bruxism; Pregnant or lactating participants; participants in chronic use of anti-inflammatory, analgesic or psychotropic drugs, patients with dental fractures, or with unsatisfactory restorations or deep caries or who use fixed, removable or total partial dentures

Design outcomes

Primary

MeasureTime frame
Reduction in the level of dentin hypersensitivity, determined by Visual Analogue Scale and Shiff scale immediately, after 3, 7, 14 and 21 days of treatment.

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactAndres;Fabiana Cardenas;de Siqueira

Universidade CEUMA;Universidade CEUMA

andresfelipemillancardenas@hotmail.com;fabisfsiqueira@hotmail.com+55(98)985074270;+55(98)985028509

Outcome results

None listed

Source: REBEC (via WHO ICTRP)